CYP1A2 rs2470102: Understanding Caffeine Metabolism Genetics
The rs2470102 variant is a genetic marker located within the CYP1A2 gene, which plays a central role in how the human body processes caffeine. Research suggests this intronic variant may influence the induction of the CYP1A2 enzyme, contributing to individual differences in caffeine metabolism rates.
What each genotype means
Typical metabolic association
This genotype is associated with the CYP1A2 gene, which plays a primary role in the metabolism of caffeine. Research into this specific variant is limited, and its direct impact on individual caffeine clearance rates remains under investigation. Please discuss any concerns regarding your caffeine sensitivity or metabolic response with a healthcare professional.
This genotype is common in many global populations, though specific frequencies vary by ancestry.
Typical metabolic association
This genotype represents a heterozygous state for the rs2470102 variant. Current scientific evidence is limited regarding how this specific combination influences CYP1A2 enzyme activity or daily caffeine metabolism. As individual responses to dietary compounds can be complex, consult with a clinician or pharmacist if you have questions about your metabolic profile.
This genotype is frequently observed across diverse populations globally.
Typical metabolic association
Carrying this genotype means you possess the alternative allele for this intronic marker. While the CYP1A2 gene is central to caffeine metabolism, the functional significance of this specific variant is not well-established in current literature. Individual metabolic rates are influenced by many factors, so please speak with a healthcare provider for personalized health insights.
This genotype is found at significant frequencies in global populations, consistent with the reported minor allele frequency of approximately 0.35.
What is the rs2470102 Variant?
The rs2470102 variant is a single-nucleotide polymorphism (SNP) situated within the CYP1A2 gene. In genetics, an intronic variant like this one resides in a non-coding region of the gene, meaning it does not directly alter the protein sequence itself. Instead, such markers are often studied for their potential to influence gene expression, regulation, or the efficiency with which the body produces the associated enzyme. Because it is located in a non-coding region, scientists investigate whether it acts as a regulatory switch that changes how much CYP1A2 enzyme is available in the liver. While many variants exist within the CYP1A2 locus, rs2470102 is specifically noted in genetic catalogs for its association with the variability observed in how different people metabolize caffeine, a substance that relies heavily on this specific enzyme pathway for clearance from the body.
The Role of the CYP1A2 Gene
The CYP1A2 gene provides instructions for making the cytochrome P450 1A2 enzyme. This enzyme is primarily expressed in the liver and is responsible for the metabolism of a wide variety of substances, including medications and dietary compounds. Most notably, CYP1A2 is responsible for approximately 95% of caffeine metabolism in humans. The activity level of this enzyme can vary significantly between individuals due to both genetic factors and environmental influences, such as smoking or the use of certain medications. When the enzyme is highly active, caffeine is cleared from the bloodstream quickly. Conversely, if the enzyme activity is lower, caffeine remains in the system for a longer duration. Understanding the genetic architecture of this gene is important because it helps explain why some people feel the effects of caffeine for many hours, while others may feel the effects wear off quite rapidly.
Research and Evidence Strength
The evidence linking rs2470102 to specific physiological outcomes is currently classified as limited. While the CYP1A2 gene is well-established as the primary engine for caffeine metabolism, the specific functional impact of the rs2470102 variant remains a subject of ongoing research. Some studies have explored how variants in this region influence caffeine intake habits and metabolic rates, but results can be mixed or dependent on specific ancestral backgrounds. It is important to note that while some CYP1A2 variants are strongly associated with enzyme inducibility, the clinical significance of rs2470102 specifically is not as robustly defined as other markers in the same gene. Because caffeine metabolism is a complex trait influenced by many genes and environmental factors like diet and smoking, it is difficult to isolate the effect of a single SNP. Consequently, researchers caution against using this variant alone to predict individual responses to caffeine or medications.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs2470102 is intended for educational purposes and should not be used to make medical decisions. You cannot use this information to diagnose a condition or determine your exact caffeine tolerance. If you are concerned about how caffeine or specific medications affect your health, it is essential to discuss these topics with a qualified clinician or pharmacist. They can provide personalized advice based on your full medical history, current medications, and lifestyle factors. Genetic testing for metabolic traits is a tool for scientific exploration, not a substitute for professional medical guidance. Always consult with a healthcare provider before making significant changes to your diet or medication regimen, as they can help you interpret how your unique biology interacts with the substances you consume.
How common is this variant?
The rs2470102 variant is relatively common, with a minor allele frequency (MAF) of approximately 0.35 across diverse global populations.
Frequently asked questions
Does my CYP1A2 genotype mean I should stop drinking coffee?
No, your genotype does not dictate your dietary choices. Caffeine metabolism is complex, and individual tolerance varies widely based on many factors beyond a single genetic variant.
Can I use this test to see if a medication will work for me?
Genetic variants in CYP1A2 can influence how some drugs are processed, but you should never use a single SNP to guide medication decisions. Always consult your doctor or pharmacist regarding drug metabolism and potential interactions.
Is rs2470102 the same as the 'fast caffeine metabolizer' gene?
While rs2470102 is in the CYP1A2 gene, other variants like rs762551 are more frequently cited in literature regarding fast versus slow caffeine metabolism. Evidence for rs2470102 is considered more limited.
Where can I find more information on my specific genetic results?
You can look up your specific rsID on databases like dbSNP or the GWAS Catalog. For clinical interpretation, always speak with a genetic counselor or your primary healthcare provider.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2470102?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1A2
This variant in the CYP1A2 gene influences the hepatic metabolism rate of caffeine and is a key marker for individual differences in caffeine clearance.
Modulates CYP1A2 inducibility affecting the rate of caffeine metabolism and clearance.
Regulatory variant associated with CYP1A2 enzyme activity, influencing the rate of caffeine metabolism and habitual coffee consumption.
A common variant in the CYP1A2 gene associated with caffeine metabolism rates.
Located in intron 1 of CYP1A2, this variant modulates inducible enzyme activity, altering systemic caffeine clearance and individual susceptibility to caffeine-related blood pressure increases.
Intronic regulatory polymorphism associated with CYP1A2 inducibility and differences in dietary caffeine metabolism rates.